Viewing Study NCT03634332

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:49 PM
Ignite Modification Date: 2026-02-28 @ 10:52 PM
Study NCT ID: NCT03634332
Status: UNKNOWN
Last Update Posted: 2019-05-07
First Post: 2018-07-23
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Second-line Study of PEGPH20 and Pembro for HA High Metastatic PDAC
Sponsor: Pancreatic Cancer Research Team
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pancreatic Ductal Adenocarcinoma View
None Pancreatic Cancer View
None Pancreatic Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None pancreatic View
None pancreas View
None cancer View
None adenocarcinoma View